A recent study evaluated the associations between various antidiabetic regimens and the incidence of cognitive disorders, including mild cognitive disorder, Alzheimer disease, and vascular dementia, in adults with type 2 diabetes. The findings suggest that certain medications ma…
Health and Human Services Secretary Robert F. Kennedy Jr. has recently claimed a 3% drop in obesity rates, attributing it partially to the Trump administration's policies. However…
GLP-1 receptor agonists, initially developed for diabetes treatment, are being studied for their effects on weight loss and metabolic health in older adults. Recent research sugge…
Researchers at UC Berkeley have discovered that the compound TOFA can enhance energy expenditure and reduce body fat without causing muscle loss in mice. This approach contrasts w…
Recent data indicates a potential decline in obesity rates in the United States, marking a significant shift in a longstanding public health issue. This change coincides with the…
A recent study published in Diabetologia reveals that the GLP-1 drug dulaglutide is more effective than standard insulin in treating diabetes associated with transfusion-dependent…
Hims & Hers Health has reported a larger-than-expected loss in the second quarter, attributed to its transition towards branded weight-loss drugs. Despite the financial setback, t…
Justin Hartley has publicly supported his former co-star Chrissy Metz as she embarks on her weight loss journey using GLP-1 medication. In a recent interview, Hartley expressed hi…
As obesity medications evolve, researchers are exploring new hormone combinations to enhance treatment effectiveness and tolerability. Current studies focus on therapies that not…
GLP-1 medications, while effective for weight loss and improving metabolic health, may also lead to emotional flatness in some users, described as the 'meh' effect. This phenomeno…
New research from Yale University has uncovered surprising effects of Ozempic, a GLP-1 medication, on hunger neurons in the brain. Contrary to previous beliefs that these neurons…
Arianna Kaesler shares her transformative experience with GLP-1 medication, which she began during her second pregnancy after being diagnosed with Alport syndrome. Struggling with…
Sofia Carson has come under fire for her appearance at the LACMA Art+Film Gala, with fans expressing concern over Hollywood's extreme beauty standards. The backlash highlights a g…
Beauty companies are racing to address the newly coined term 'Ozempic face' as they develop treatments for facial volume loss linked to rapid weight loss, further complicating the…
Fitness coach Jacob Zemer outlines key strategies to help adults slow muscle loss as they age. He emphasizes the importance of strength training, adequate protein intake, and qual…
NVIDIA and Eli Lilly have both reported impressive quarterly earnings, showcasing their respective growth potential. NVIDIA's revenue surged by over 105% year-over-year, driven by…
Novo Nordisk's stock fell by 7% after the company revealed its long-term growth strategy at a capital markets day, raising investor concerns about its ability to maintain its posi…
In a stunning twist of regulatory fate, the FDA has issued new hair-raising guidelines for users of GLP-1 drugs like Ozempic and Mounjaro, warning of a 37-68% increased risk of ha…